15 MIN DELAY
Latest Share Price
Latest NewsPress Releases Regulatory News
About our products
No company endeavours to do more to help interventional specialists in their quest to see more, reach further and treat smarter.
Our pharmaceuticals portfolio offers antidotes that alleviate acute toxicities.
Named Patient Supplies
Under strict regulations, we are permitted to allow healthcare professionals access to certain products still in the pre-approval phase.
18 Jun 2018
BTG plc Annual Report and Accounts 2018
At BTG, we are focused on bringing to market innovative products in specialist areas of medicine to better serve doctors and patients.Read the report here
Interventional Oncology meets Immuno-Oncology
We're exploring how our locoregional therapies might work alongside immunotherapeutics to help drive patients’ own immune system to fight cancer.Learn more
BTG’s success stems from the hard work and contributions of our people. As we grow, we need people who share our values and exhibit the behaviors that make working here different.Careers
10 Apr 2018
If immuno-oncology is going to be a silver bullet, we may need help with the aim.
BTG is partnering with the Society of Interventional Oncology to support a multidisciplinary approach to turn the body’s immune system into a cancer-fighting weapon.Read more
We are committed to ensuring that we provide full, accurate, balanced and timely information to the medical professionals who prescribe our products.Healthcare Professionals
15 May 2018
Financial Results Center 2018
Results statement, webcast details, and presentation for the year ending 31 March 2018Find out more
Innovation is a continuous process at BTG that starts with the needs of patients and an in-depth knowledge of our customers.Innovation